Andrew N Hoofnagle
Overview
Explore the profile of Andrew N Hoofnagle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
268
Citations
6419
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nierves L, Lin T, Moradian A, Shen Q, Sechi S, MacCoss M, et al.
J Clin Endocrinol Metab
. 2025 Mar;
PMID: 40056450
The prevalence of diabetes, particularly type 2 diabetes, has reached epidemic proportions globally. The number of patients with type 1 diabetes (T1D) is also increasing rapidly. Despite advancements in understanding...
2.
Lidgard B, Hoofnagle A, Zelnick L, de Boer I, Fretts A, Kestenbaum B, et al.
Kidney Med
. 2025 Feb;
7(3):100954.
PMID: 39967827
No abstract available.
3.
Cheng J, Hoofnagle A, Katz R, Kritchevsky S, Shlipak M, Sarnak M, et al.
JBMR Plus
. 2025 Feb;
9(3):ziaf001.
PMID: 39925623
Vitamin D deficiency is common across the world. However, the standard clinical biomarker for vitamin D, 25OHD, may be a poor marker of vitamin D status, as most of circulating...
4.
Schweppe D, Beliveau B, Hoofnagle A
JAMA
. 2025 Jan;
333(10):898-899.
PMID: 39883454
No abstract available.
5.
Best C, Li X, Rotter J, Prince D, Hsu S, Hoofnagle A, et al.
J Clin Endocrinol Metab
. 2025 Jan;
PMID: 39815761
Context: The response to treatment with vitamin D varies between patients. Objective: To identify genetic variants associated with the biochemical response to vitamin D3 supplementation. Design: Randomized placebo-controlled trial conducted...
6.
Wise S, Cavalier E, Lukas P, Peeters S, Le Goff C, Briggs L, et al.
Anal Bioanal Chem
. 2025 Jan;
PMID: 39789379
Commutability is where the measurement response for a reference material (RM) is the same as for an individual patient sample with the same concentration of analyte measured using two or...
7.
Huynh H, Barahona-Carrillo L, Moncrieffe D, Cowan D, Forrest K, Becker J, et al.
Drug Test Anal
. 2024 Oct;
PMID: 39462787
The amino-terminal propeptide of type III procollagen (P-III-NP) is used with IGF-I to detect the illicit use of growth hormone and to monitor growth hormone therapy. However, the only currently...
8.
Liao H, Phipps W, Keebaugh M, Hoofnagle A, Baird G
Clin Chim Acta
. 2024 Oct;
565:119995.
PMID: 39389216
Background: The opioid epidemic has underscored the importance of urine drug testing in the management of chronic pain. However, interpreting test results can be challenging, especially in scenarios where medications...
9.
Kogon A, Ballester L, Zee J, Walker N, Zaritsky J, Atkinson M, et al.
Pediatr Nephrol
. 2024 Sep;
39(12):3627-3628.
PMID: 39264421
No abstract available.
10.
Tsantilas K, Merrihew G, Robbins J, Johnson R, Park J, Plubell D, et al.
J Proteome Res
. 2024 Sep;
23(10):4392-4408.
PMID: 39248652
A thorough evaluation of the quality, reproducibility, and variability of bottom-up proteomics data is necessary at every stage of a workflow, from planning to analysis. We share vignettes applying adaptable...